Insulin-like growth factor-binding protein-5 activates plasminogen by interaction with tissue plasminogen activator, independently of its ability to bind to plasminogen activator inhibitor-1, insulin-like growth factor-I, or heparin

Journal of Biological Chemistry

Volumn 281, Issue 16, 2006, Pages 10883-10889

  Sorrell, Alice M ^a   Shand, John H ^a   Tonner, Elizabeth ^a   Gamberoni, Matteo ^b   Accorsi, Pier A ^b   Beattie, James ^a   Allan, Gordon J ^a   Flint, David J ^a  

^a HANNAH RESEARCH INSTITUTE   (United Kingdom)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESION; BIOSENSORS; CELLS; MUTAGENESIS; PROTEINS;

CELL DEATH; TISSUE PLASMINOGEN ACTIVATOR (TPA); UROKINASE PLASMINOGEN ACTIVATOR (UPA);

INSULIN;

HEPARIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BIOSENSOR; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DRUG EFFECT; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PURIFICATION;

ANIMALS; BIOSENSING TECHNIQUES; CARBOXYPEPTIDASE B; CASPASE 3; CASPASES; CELL DEATH; CELL LINE; CELL-FREE SYSTEM; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CULTURE MEDIA, SERUM-FREE; ESCHERICHIA COLI; FOCAL ADHESIONS; GLUTATHIONE TRANSFERASE; HEPARIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, TRANSGENIC; MUTATION; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATORS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

MUS MUSCULUS;

EID: 33744959628     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M508505200     Document Type: Article

References (37)

1. Tonner, E., Barber, M. C., Travers, M. T., Logan, A., and Flint, D. J. (1997) Endocrinology 138, 5101-5107
2. Tonner, E., Barber, M. C., Allan, G. J., Beattie, J., Webster, J., Whitelaw, C. B., and Flint, D. J. (2002) Development (Camb.) 129, 4547-4557
3. Allan, G. J., Tonner, E., Barber, M. C., Travers, M. T., Shand, J. H., Vernon, R. G., Kelly, P. A., Binart, N., and Flint, D. J. (2002) Endocrinology 143, 4310-4319
4. Marshman, E., Green, K. A., Flint, D. J., White, A., Streuli, C. H., and Westwood, M. (2003) J. Cell Sci. 116, 675-682
5. Boutinaud, M., Shand, J. H., Park, M. A., Phillips, K., Beattie, J., Flint, D. J., and Allan, G. J. (2004) J. Mol. Endocrinol. 33, 195-207
6. Lund, L. R., Romer, J., Thomasset, N., Solberg, H., Pyke, C., Bissell, M. J., Dano, K., and Werb, Z. (1996) Development (Camb.) 122, 181-193
7. Nam, T. J., Busby, W., Jr., and Clemmons, D. R. (1997) Endocrinology 138, 2972-2978
8. Perks, C. M., McCaig, C., Clarke, J. B., Clemmons, D. R., and Holly, J. M. (2002) Biochem. Biophys. Res. Commun. 294, 995-1000
9. Perks, C. M., McCaig, C., Clarke, J. B., Clemmons, D. R., and Holly, J. M. (2002) Biochem. Biophys. Res. Commun. 294, 988-994
10. Flint, D. J., Tonner, E., and Allan, G. J. (2000) J. Mammary Gland Biol. Neoplasia 5, 65-73
11. Tonner, E., Allan, G. J., and Flint, D. J. (2000) J. Endocrinol. 167, 265-273
12. Heegaard, C. W., Andreasen, P. A., Petersen, T. E., and Rasmussen, L. K. (1997) Fibrinolysis Proteolysis 11, 29-36
13. Danielson, K. G., Oborn, C. J., Durban, E. M., Butel, J. S., and Medina, D. (1984) Proc. Natl. Acad. Sci. U. S. A. 81, 3756-3760
14. Phillips, K., Park, M. A., Quarrie, L. H., Boutinaud, M., Lochrie, J. D., Flint, D. J., Allan, G. J., and Beattie, J. (2003) J. Mol. Endocrinol. 31, 197-208
15. Berkenpas, M. B., Lawrence, D. A., and Ginsburg, D. (1995) EMBO J. 14, 2969-2977
16. Deugnier, M. A., Faraldo, M. M., Rousselle, P., Thiery, J. P., and Glukhova, M. A. (1999) J. Cell Sci. 112, 1035-1044
17. Anonick, P. K., and Gonias, S. L. (1991) Biochem. J. 275, 53-59
18. Nieuwenhuizen, W. (2001) Ann. N. Y. Acad. Sci. 936, 237-246
19. Shand, J. H., Beattie, J., Song, H., Phillips, K., Kelly, S. M., Flint, D. J., and Allan, G. J. (2003) J. Biol. Chem. 278, 17859-17866
20. Imai, Y., Moralez, A., Andag, U., Clarke, J. B., Busby, W. H., Jr., and Clemmons, D. R. (2000) J. Biol. Chem. 275, 18188-18194
21. Song, H., Beattie, J., Campbell, I. W., and Allan, G. J. (2000) J. Mol. Endocrinol. 24, 43-51
22. Allan, G. J., Tonner, E., Szymanowska, M., Shand, J. H., Kelly, S. M., Phillips, K., Clegg, R. A., Gow, I. F., Beattie, J., and Flint, D. J. (2005) Endocrinology 147, 338-349
23. Song, H., Shand, J. H., Beattie, J., Flint, D. J., and Allan, G. J. (2001) J. Mol. Endocrinol. 26, 229-239
24. Bramani, S., Song, H., Beattie, J., Tonner, E., Flint, D. J., and Allan, G. J. (1999) J. Mol. Endocrinol. 23, 117-123
25. Beattie, J., Phillips, K., Shand, J. H., Szymanowska, M., Flint, D. J., and Allan, G. J. (2005) J. Mol. Endocrinol. 34, 163-175
26. Fischer, B. (1990) Biol. Chem. Hoppe-Seyler 371, 1067-1075
27. Bajzar, L., Manuel, R., and Nesheim, M. E. (1995) J. Biol. Chem. 270, 14477-14484
28. Bajzar, L., Morser, J., and Nesheim, M. (1996) J. Biol. Chem. 271, 16603-16608
29. Fischer, B. E. (1992) Blood Coagul. Fibrinolysis 3, 197-204
30. Christy, J. R., and Macleod, N. (1989) Cardiovasc. Res. 23, 949-959
31. Zheng, B., Duan, C., and Clemmons, D. R. (1998) J. Biol. Chem. 273, 8994-9000
32. Jones, J. I., Doerr, M. E., and Clemmons, D. R. (1995) Prog. Growth Factor Res. 6, 319-327
33. Nam, T. J., Busby, W. H., Jr., Rees, C., and Clemmons, D. R. (2000) Endocrinology 141, 1100-1106
34. Ossowski, L., Biegel, D., and Reich, E. (1979) Cell 16, 929-940
35. Talhouk, R. S., Bissell, M. J., and Werb, Z. (1992) J. Cell Biol. 118, 1271-1282
36. Busso, N., Huarte, J., Vassalli, J. D., Sappino, A. P., and Belin, D. (1989) J. Biol. Chem. 264, 7455-7457
37. Andreasen, P. A., Egelund, R., and Petersen, H. H. (2000) Cell. Mol. Life Sci. 57, 25-40